about
Poly(beta-aminosulfonamides) as gene delivery vectors: synthesis and in vitro screening.Cancer gene therapy: developments to 2000.Tissue-specific transcriptional targeting of a replication-competent retroviral vectorA promising gene delivery system developed from PEGylated MoS2 nanosheets for gene therapy.Immunotherapy for nonmelanoma skin cancer: does it have a future?Clinical proteomics: translating benchside promise into bedside reality.Progress and limitations in cancer gene therapy.Therapeutic potential of antisense nucleic acid molecules.Microspheres for controlled release drug delivery.Delivery of a transforming growth factor β-1 plasmid to mesenchymal stem cells via cationized Pleurotus eryngii polysaccharide nanoparticlesGene therapy and virotherapy of gastric cancer: preclinical results and clinical developments.Gene- and immunotherapy for hepatocellular carcinoma.Cancer-specific targeting of a conditionally replicative adenovirus using mRNA translational controlNucleic acid therapeutics for hematologic malignancies--theoretical considerations.Gene therapy in head and neck cancer: a review.Telomerase-specific oncolytic virotherapy for human hepatocellular carcinoma.Dual-degradable disulfide-containing PEI-Pluronic/DNA polyplexes: transfection efficiency and balancing protection and DNA release.Gene therapy for cancer through adenovirus vector‑mediated expression of the Ad5 early region gene 1A based on loss of IGF2 imprinting.Tumor and vascular targeting of a novel oncolytic measles virus retargeted against the urokinase receptor.Balancing protection and release of DNA: tools to address a bottleneck of non-viral gene delivery.Update on oncolytic viral therapy - targeting angiogenesisViral gene therapy for head and neck cancer.The third annual BRDS on research and development of nucleic acid-based nanomedicines.Bystander killing of malignant cells via the delivery of engineered thymidine-active deoxycytidine kinase for suicide gene therapy of cancer.Insertion or deletion of the Cheo box modifies radiation inducibility of Clostridium promoters.Effect of decorin on overcoming the extracellular matrix barrier for oncolytic virotherapy.Effect of sonoporation on cationic liposome-mediated IFNbeta gene therapy for metastatic hepatic tumors of murine colon cancer.Potent antitumor efficacy of XAF1 delivered by conditionally replicative adenovirus vector via caspase-independent apoptosis.Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cells.Replicating retroviral vectors mediating continuous production and secretion of therapeutic gene products from cancer cells.Short and highly efficient synthetic promoters for melanoma-specific gene expression.Tumor-specific gene therapy for uterine cervical cancer using MN/CA9-directed replication-competent adenovirus.Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity.Effects of adenovirus-mediated SV5 fusogenic glycoprotein expression on tumor cells.Efficient dose-dependent and time-dependent protein transduction of pancreatic carcinoma cells in vitro and in vivo using purified VP22-EGFP fusion protein.Transcriptional targeting of conditionally replicating adenovirus to dividing endothelial cells.Reconstitution of antigen presentation in HLA class I-negative cancer cells with peptide-beta2m fusion molecules.Using intron splicing trick for preferential gene expression in transduced cells: an approach for suicide gene therapy.Replicative retroviral vectors for cancer gene therapy.Reduced growth in response to ganciclovir treatment of subcutaneous xenografts expressing HSV-tk in the vascular compartment.
P2860
Q33315636-CFF0C440-3164-4143-8176-BF1DBC090A98Q34090963-CB470C91-32F1-47B8-9C0A-86B923933F42Q34350999-35883810-D6FF-456A-BFBB-6EA9D6567CCEQ34435548-F667CB48-DEDA-47D4-8F4E-273D85526AECQ34568136-17A826E2-C131-42F1-A7D5-5720504F488BQ34810370-FA53710E-2BDA-4182-AA46-3B14FBDDBB26Q35051969-46C1BAC8-99D0-4832-8A1E-3D28E6B48A0EQ35570262-DE701B4D-A948-471F-B062-6E02A16035C6Q35609775-3FE35D6D-24F4-4723-8955-A5BA323CC37CQ35846835-B9E0DB50-7433-41D6-9939-265BC80D6544Q36090054-CFBE9FE6-6A98-4EBA-9215-98904DBEE073Q36150432-DC5F01CA-6647-43EE-AD74-8ADA41E10819Q36498617-908D4BFE-4F74-4EFE-803F-3D03590F149BQ36673652-18CF5DF1-96C8-4F83-9F12-7229E30DAE39Q37023446-89481D49-065C-4378-A714-E4978B4235B3Q37212969-6E984590-06D1-43A7-84BD-A3A3F7924F5BQ37221056-E2CC9C6B-DEAE-4770-A6B4-182D5CB8D599Q37260599-377B4320-8455-4389-807D-13E8F66098CAQ37336713-00F7F4F4-82DA-4412-B58A-756380F09727Q37592852-42ADC1D9-19F3-4827-96A7-696EF87228FAQ38128561-61B12AB4-F04B-433A-BA0D-9C5C0B198BACQ38381706-1A3F7939-8301-4E4C-88D1-34C9817A04D6Q39184710-3155362A-1763-428C-A2CA-B7CB505A1AE7Q39386066-B6BCED6C-46AF-499D-BE0A-3884E687F6CAQ39492726-013004B3-D156-4E61-B982-85D7F659FD15Q39775919-44C22891-2AA9-4572-AF1A-93899C7742AFQ39842450-2F59A6F3-AB6F-454E-848B-2C05187D2DDAQ40226159-29A8A3EC-BB32-439A-B693-3C1674F0F6B4Q40371833-801444AE-B7CE-4A64-B1C3-BE2B9D2FAC20Q40461869-8E73DEB7-9DE0-44F3-9A13-75A79D4241D0Q40476867-063D9DD7-C4D6-4A2A-9775-30A1F4E108F6Q40551014-26B6C49D-EDC1-44EB-AB1E-4A9E77EEC455Q40573317-27933B30-4042-4ADD-BC9B-CA14845716BEQ40641134-84E502F5-7E41-4A9D-AB5F-93D96F326821Q40656529-F3318CBB-DEC5-4974-A7E4-7B47F8D49742Q40722083-E1D1F88F-62C7-47A5-A453-960D300B3767Q40827292-EAE7D80C-BF32-4EAD-99DE-211DF1BC9773Q41040429-5EF0EC30-1EB1-43DF-95E8-3A2ADC072231Q42807227-6EE372D5-5698-4346-AA98-38ABA85A5BCCQ43653599-37C8AFBD-C3DC-414C-BC97-2056AE623D92
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Cancer gene therapy: hard lessons and new courses.
@ast
Cancer gene therapy: hard lessons and new courses.
@en
type
label
Cancer gene therapy: hard lessons and new courses.
@ast
Cancer gene therapy: hard lessons and new courses.
@en
prefLabel
Cancer gene therapy: hard lessons and new courses.
@ast
Cancer gene therapy: hard lessons and new courses.
@en
P2093
P2860
P356
P1433
P1476
Cancer gene therapy: hard lessons and new courses.
@en
P2093
P2860
P2888
P356
10.1038/SJ.GT.3301084
P577
2000-01-01T00:00:00Z
P5875
P6179
1032661544